Blend Labs (NYSE:BLND - Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a "sell" rating to a "hold" rating in a note issued to investors on Sunday.
Several other equities research analysts also recently issued reports on the company. Keefe, Bruyette & Woods cut their price target on Blend Labs from $4.00 to $3.75 and set a "market perform" rating for the company in a report on Friday, August 8th. The Goldman Sachs Group cut their price target on Blend Labs from $5.60 to $4.80 and set a "buy" rating for the company in a report on Monday, May 12th. JMP Securities reaffirmed a "market outperform" rating and set a $7.00 price target on shares of Blend Labs in a report on Wednesday, May 28th. Canaccord Genuity Group reiterated a "buy" rating and set a $5.25 price objective on shares of Blend Labs in a research report on Monday, May 12th. Finally, UBS Group lowered their price objective on Blend Labs from $4.00 to $3.50 and set a "neutral" rating on the stock in a research report on Friday, August 8th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, Blend Labs currently has an average rating of "Moderate Buy" and a consensus price target of $4.88.
Get Our Latest Stock Analysis on BLND
Blend Labs Stock Up 12.6%
Shares of NYSE BLND traded up $0.3750 during trading hours on Friday, hitting $3.3550. The company had a trading volume of 756,040 shares, compared to its average volume of 2,830,891. The stock has a market capitalization of $871.16 million, a P/E ratio of -22.37 and a beta of 1.24. Blend Labs has a 1-year low of $2.63 and a 1-year high of $5.53. The firm's 50 day moving average is $3.34 and its 200-day moving average is $3.44.
Blend Labs (NYSE:BLND - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The company reported ($0.03) EPS for the quarter, missing the consensus estimate of $0.02 by ($0.05). The firm had revenue of $31.52 million during the quarter, compared to the consensus estimate of $31.93 million. Blend Labs has set its Q3 2025 guidance at EPS. On average, sell-side analysts predict that Blend Labs will post -0.19 earnings per share for the current year.
Insiders Place Their Bets
In related news, insider Brian Kneafsey sold 25,000 shares of the firm's stock in a transaction on Friday, August 15th. The stock was sold at an average price of $2.87, for a total value of $71,750.00. Following the transaction, the insider owned 696,598 shares in the company, valued at approximately $1,999,236.26. This trade represents a 3.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Nima Ghamsari sold 311,886 shares of the firm's stock in a transaction on Thursday, August 14th. The stock was sold at an average price of $2.90, for a total value of $904,469.40. Following the completion of the transaction, the insider owned 5,754,051 shares in the company, valued at $16,686,747.90. The trade was a 5.14% decrease in their position. The disclosure for this sale can be found here. Insiders sold 561,736 shares of company stock worth $1,739,383 in the last 90 days. 35.52% of the stock is owned by company insiders.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the business. Captrust Financial Advisors bought a new position in Blend Labs in the second quarter valued at about $35,000. Merit Financial Group LLC bought a new position in Blend Labs in the first quarter valued at about $36,000. Universal Beteiligungs und Servicegesellschaft mbH bought a new position in Blend Labs in the second quarter valued at about $37,000. Jump Financial LLC bought a new position in Blend Labs in the second quarter valued at about $38,000. Finally, Quadrature Capital Ltd bought a new position in Blend Labs in the second quarter valued at about $40,000. Institutional investors own 52.56% of the company's stock.
About Blend Labs
(
Get Free Report)
Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.
Further Reading

Before you consider Blend Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Blend Labs wasn't on the list.
While Blend Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.